RANDOMIZED CLINICAL TRIAL COMPARING TRANSURETHRAL PROSTATE RESECTION (TURP) AND ECHOLASER SORACTELITE-TPLA (TRANSPERINEAL LASER ABLATION) IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC OBSTRUCTION
1 other identifier
interventional
80
1 country
2
Brief Summary
THIS STUDY IS A RANDOMIZED CLINICAL TRIAL COMPARING TRANSURETHRAL PROSTATE RESECTION (TURP) AND ECHOLASER SORACTELITE-TPLA (TRANSPERINEAL LASER ABLATION) IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC OBSTRUCTION. THE PRIMARY GOAL IS TO SHOW THE NON-INFERIORITY OF TPLA VERSUS TURP BY IPSS-SCORE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2024
CompletedFirst Submitted
Initial submission to the registry
December 4, 2025
CompletedFirst Posted
Study publicly available on registry
December 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2026
ExpectedDecember 17, 2025
December 1, 2025
1.4 years
December 4, 2025
December 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
IS TO SHOW THE NON-INFERIORITY OF TPLA VERSUS TURP BY IPSS-SCORE
one, three, six, twelve mounth after treatment
Secondary Outcomes (2)
COMPARE Q-MAX UROFLOW
one, three, six, twelve mounth after treatment
COMPARE INPATIENT-TIMING
one, three, six, twelve mounth after treatment
Study Arms (2)
TPLA
OTHERPatients underwent TPLA tretment
TURP
OTHERPatients underwent TURP tretment
Interventions
transperineal laser ablation of prostatic adenoma, by transrectal ultrasound guide.
Eligibility Criteria
You may qualify if:
- age, Lower urinary tract simptoms (IPSS \>= 8), uncompliance or no achived drugs treatment for IPB, prostate volume 40ml-80ml , ability to express informed consent.
You may not qualify if:
- previous surgical tretment for IPB, bladder catheter, bladder stones, urinary or seminal infections, hypo-/a-contractilitis of bladder, bladder tuomrs, urethral stricture, neurological bladder, refuse to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
UOC Urologia e Trapianti di Rene Policlinico di Bari
Bari, ITALY/Bari, 70124, Italy
UOC Urologia e Trapianti di Rene Policlinico di Bari
Bari, ITALY/Bari, 70124, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 4, 2025
First Posted
December 17, 2025
Study Start
July 14, 2024
Primary Completion
December 25, 2025
Study Completion (Estimated)
December 25, 2026
Last Updated
December 17, 2025
Record last verified: 2025-12